HOW MUCH YOU NEED TO EXPECT YOU'LL PAY FOR A GOOD ABBV-744 COMBINATION THERAPY WITH CHEMOTHERAPY

In Section C, individuals will receive ABBV-744 and oral navitoclax. In Section D, contributors will acquire ABBV-744 and ruxolitinib. Participants will obtain treatment right until ailment progression or the individuals are unable to tolerate the study drugs.For all stream cytometry experiments, 10,000 cells for each replicate were being analyzed,